vs

Side-by-side financial comparison of Xos, Inc. (XOS) and cbdMD, Inc. (YCBD). Click either name above to swap in a different company.

Xos, Inc. is the larger business by last-quarter revenue ($5.2M vs $5.0M, roughly 1.0× cbdMD, Inc.). cbdMD, Inc. runs the higher net margin — -5.6% vs -186.8%, a 181.2% gap on every dollar of revenue. On growth, cbdMD, Inc. posted the faster year-over-year revenue change (-1.9% vs -54.5%). Over the past eight quarters, cbdMD, Inc.'s revenue compounded faster (7.1% CAGR vs -35.7%).

Xos, Inc. is an American manufacturer of commercial electric vehicles (EVs) and mobile EV chargers.

cbdMD, Inc. is a U.S.-based consumer wellness company that manufactures and distributes hemp-derived CBD products, including tinctures, topicals, gummies, pet care items, and bath products. All offerings undergo third-party quality testing, and are sold via e-commerce platforms, brick-and-mortar retail stores, and wellness partner channels primarily across the United States.

XOS vs YCBD — Head-to-Head

Bigger by revenue
XOS
XOS
1.0× larger
XOS
$5.2M
$5.0M
YCBD
Growing faster (revenue YoY)
YCBD
YCBD
+52.6% gap
YCBD
-1.9%
-54.5%
XOS
Higher net margin
YCBD
YCBD
181.2% more per $
YCBD
-5.6%
-186.8%
XOS
Faster 2-yr revenue CAGR
YCBD
YCBD
Annualised
YCBD
7.1%
-35.7%
XOS

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
XOS
XOS
YCBD
YCBD
Revenue
$5.2M
$5.0M
Net Profit
$-9.8M
$-283.1K
Gross Margin
-50.5%
59.8%
Operating Margin
-186.6%
-5.7%
Net Margin
-186.8%
-5.6%
Revenue YoY
-54.5%
-1.9%
Net Profit YoY
48.6%
-1975.7%
EPS (diluted)
$-0.76

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
XOS
XOS
YCBD
YCBD
Q4 25
$5.2M
$5.0M
Q3 25
$16.5M
$4.7M
Q2 25
$18.4M
$4.6M
Q1 25
$5.9M
$4.7M
Q4 24
$11.5M
$5.1M
Q3 24
$15.8M
$4.6M
Q2 24
$15.5M
$5.2M
Q1 24
$12.6M
$4.4M
Net Profit
XOS
XOS
YCBD
YCBD
Q4 25
$-9.8M
$-283.1K
Q3 25
$2.1M
$-680.0K
Q2 25
$-7.5M
$-895.3K
Q1 25
$-10.2M
$-480.8K
Q4 24
$-19.0M
$15.1K
Q3 24
$-10.5M
$-152.8K
Q2 24
$-9.7M
$459.7K
Q1 24
$-11.0M
$-3.0M
Gross Margin
XOS
XOS
YCBD
YCBD
Q4 25
-50.5%
59.8%
Q3 25
15.3%
58.8%
Q2 25
8.8%
61.5%
Q1 25
20.6%
62.3%
Q4 24
-32.4%
66.5%
Q3 24
18.1%
53.9%
Q2 24
13.1%
65.8%
Q1 24
22.1%
59.0%
Operating Margin
XOS
XOS
YCBD
YCBD
Q4 25
-186.6%
-5.7%
Q3 25
-42.4%
-14.5%
Q2 25
-38.5%
-19.6%
Q1 25
-157.7%
-10.2%
Q4 24
-127.0%
-1.7%
Q3 24
-61.4%
-6.9%
Q2 24
-73.2%
-7.4%
Q1 24
-81.1%
-35.4%
Net Margin
XOS
XOS
YCBD
YCBD
Q4 25
-186.8%
-5.6%
Q3 25
12.9%
-14.4%
Q2 25
-40.8%
-19.4%
Q1 25
-173.3%
-10.1%
Q4 24
-165.4%
0.3%
Q3 24
-66.6%
-3.4%
Q2 24
-62.2%
8.9%
Q1 24
-87.1%
-68.8%
EPS (diluted)
XOS
XOS
YCBD
YCBD
Q4 25
$-0.76
Q3 25
$0.22
Q2 25
$-0.91
Q1 25
$-1.26
Q4 24
$-2.34
Q3 24
$-1.32
Q2 24
$-1.23
$-0.15
Q1 24
$-1.80
$-1.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
XOS
XOS
YCBD
YCBD
Cash + ST InvestmentsLiquidity on hand
$14.0M
$3.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$23.3M
$9.0M
Total Assets
$60.4M
$11.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
XOS
XOS
YCBD
YCBD
Q4 25
$14.0M
$3.4M
Q3 25
$14.1M
$2.3M
Q2 25
$8.8M
$1.1M
Q1 25
$4.8M
$1.8M
Q4 24
$11.0M
$2.0M
Q3 24
$8.4M
$2.5M
Q2 24
$19.7M
$2.4M
Q1 24
$46.2M
$2.1M
Stockholders' Equity
XOS
XOS
YCBD
YCBD
Q4 25
$23.3M
$9.0M
Q3 25
$31.1M
$7.2M
Q2 25
$18.3M
$6.1M
Q1 25
$24.8M
$665.8K
Q4 24
$33.6M
$1.8M
Q3 24
$50.8M
$2.0M
Q2 24
$59.2M
$3.0M
Q1 24
$67.8M
$3.1M
Total Assets
XOS
XOS
YCBD
YCBD
Q4 25
$60.4M
$11.8M
Q3 25
$73.8M
$10.4M
Q2 25
$80.3M
$9.9M
Q1 25
$87.7M
$10.9M
Q4 24
$98.3M
$11.5M
Q3 24
$120.5M
$10.6M
Q2 24
$123.4M
$13.8M
Q1 24
$135.0M
$14.6M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
XOS
XOS
YCBD
YCBD
Operating Cash FlowLast quarter
$2.4M
$-812.5K
Free Cash FlowOCF − Capex
$-977.3K
FCF MarginFCF / Revenue
-19.5%
Capex IntensityCapex / Revenue
0.0%
3.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-2.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
XOS
XOS
YCBD
YCBD
Q4 25
$2.4M
$-812.5K
Q3 25
$3.1M
$-240.7K
Q2 25
$4.6M
$-704.2K
Q1 25
$-4.8M
$-189.5K
Q4 24
$3.3M
$-317.9K
Q3 24
$-11.5M
$167.4K
Q2 24
$-26.0M
$289.8K
Q1 24
$-14.6M
$-704.1K
Free Cash Flow
XOS
XOS
YCBD
YCBD
Q4 25
$-977.3K
Q3 25
$-243.6K
Q2 25
$-705.7K
Q1 25
$-205.0K
Q4 24
$-482.3K
Q3 24
$-11.7M
$157.4K
Q2 24
$-26.1M
Q1 24
$-14.6M
$-708.7K
FCF Margin
XOS
XOS
YCBD
YCBD
Q4 25
-19.5%
Q3 25
-5.2%
Q2 25
-15.3%
Q1 25
-4.3%
Q4 24
-9.4%
Q3 24
-73.9%
3.5%
Q2 24
-168.1%
Q1 24
-115.7%
-16.2%
Capex Intensity
XOS
XOS
YCBD
YCBD
Q4 25
0.0%
3.3%
Q3 25
0.0%
0.1%
Q2 25
0.0%
0.0%
Q1 25
0.0%
0.3%
Q4 24
0.0%
3.2%
Q3 24
0.9%
0.2%
Q2 24
0.8%
0.0%
Q1 24
0.2%
0.1%
Cash Conversion
XOS
XOS
YCBD
YCBD
Q4 25
Q3 25
1.45×
Q2 25
Q1 25
Q4 24
-21.06×
Q3 24
Q2 24
0.63×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

XOS
XOS

Segment breakdown not available.

YCBD
YCBD

Sales Channel Directly To Consumer$3.6M72%
Sales Channel Through Intermediary$1.4M28%

Related Comparisons